glp-3rt retatrutide (GLP-3) – Y&P Labs Retatrutide (GLP-3) — Peptide Triple
Description
Feel Fuller
Retatrutide produces higher rates of nausea (43% vs 20-47%), diarrhea (33% vs lower), and vomiting (21% vs lower) at their respective maintenance doses
What can I expect when starting semaglutide
A physician reviews your case, picks the right form and starting dose, and, if appropriate, prescribes Zepbound
For example, semaglutide (Ozempic) has a half-life of ~7 days
Ozempic and Rybelsus are not FDA approved to treat type 2 diabetes
